secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2023-01-11T23:59:59+00:00
Accession:  0001628908-23-000005
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolent Health reaffirms FY2022 revenue and Adjusted EBITDA guidance at J.P. Morgan conference
--------------------------------------------------------------------------------

- Reaffirmed previously issued revenue and Adjusted EBITDA guidance for full year 2022.
- Presenting at 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023.
- Guidance based on preliminary, unaudited financials; actual results may differ materially.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000005/0001628908-23-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000005/evh-20230111.htm
  HTML page:      https://secwatch.observer/filing/0001628908-23-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer